IVETTE CRUZ

Dr. IVETTE CRUZ

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2010 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
PAPaloma Almeda-Valdés
Paloma Almeda-Valdés
DCDaniel Cuevas-Ramos
Daniel Cuevas-Ramos
RMRoopa Mehta
Roopa Mehta
FGFrancisco J Gomez-Perez
Francisco J Gomez-Perez
ICIVETTE CRUZ
IVETTE CRUZ
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
Background: Insulin resistance (IR) and related metabolic disturbances are characterized by low levels of adiponectin. High molecular weight adiponectin (HMWA) is considered the active form of adiponectin and a better marker of IR than total adiponectin. The objective of this study is to compare the utility of total adiponectin, HMWA and the HMWA/total adiponectin index (SA index) for the identification of IR and related metabolic conditions. Methods: A cross-sectional analysis was performed in a group of ambulatory subjects, aged 20 to 70 years, in Mexico City. Areas under the receiver operator characteristic (ROC) curve for total, HMWA and the SA index were plotted for the identification of metabolic disturbances. Sensitivity and specificity, positive and negative predictive values, and accuracy for the identification of IR were calculated. Results: The study included 101 men and 168 women. The areas under the ROC curve for total and HMWA for the identification of IR (0.664 vs. 0.669, P = 0.74), obesity (0.592 vs. 0.610, P = 0.32), hypertriglyceridemia (0.661 vs. 0.671, P = 0.50) and hypoalphalipoproteinemia (0.624 vs. 0.633, P = 0.58) were similar. A total adiponectin level of 8.03 μg/ml was associated with a sensitivity of 57.6%, a specificity of 65.9%, a positive predictive value of 50.0%, a negative predictive value of 72.4%, and an accuracy of 62.7% for the diagnosis of IR. The corresponding figures for a HMWA value of 4.25 μg/dl were 59.6%, 67.1%, 51.8%, 73.7% and 64.2%. The area under the ROC curve of the SA index for the identification of IR was 0.622 [95% CI 0.554-0.691], obesity 0.613 [95% CI 0.536-0.689], hypertriglyceridemia 0.616 [95% CI 0.549-0.683], and hypoalphalipoproteinemia 0.606 [95% CI 0.535-0.677]. Conclusions: Total adiponectin, HMWA and the SA index had similar utility for the identification of IR and metabolic disturbances.

1 October 2018 in Atherosclerosis
Verified
Journal Article
Closed access
RMRoopa Mehta
Roopa Mehta
EREnrique Reyes-Rodríguez
Enrique Reyes-Rodríguez
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
AGAna Carmen Guerrero-Díaz
Ana Carmen Guerrero-Díaz
AVArsenio Vargas-Vázquez
Arsenio Vargas-Vázquez
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas

28 April 2019 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
OAOlimpia Arellano-Campos
Olimpia Arellano-Campos
DGDonaji V. Gómez-Velasco
Donaji V. Gómez-Velasco
OBOmar Yaxmehen Bello-Chavolla
Omar Yaxmehen Bello-Chavolla
ICIVETTE CRUZ
IVETTE CRUZ
MHMarco Melgarejo Hernandez
Marco Melgarejo Hernandez
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
Type 2 diabetes mellitus (T2D) is a leading cause of morbidity and mortality in Mexico. Here, we aimed to report incidence rates (IR) of type 2 diabetes in middle-aged apparently-healthy Mexican adults, identify risk factors associated to ID and develop a predictive model for ID in a high-risk population. Prospective 3-year observational cohort, comprised of apparently-healthy adults from urban settings of central Mexico in whom demographic, anthropometric and biochemical data was collected. We evaluated risk factors for ID using Cox proportional hazard regression and developed predictive models for ID. We included 7636 participants of whom 6144 completed follow-up. We observed 331 ID cases (IR: 21.9 per 1000 person-years, 95%CI 21.37–22.47). Risk factors for ID included family history of diabetes, age, abdominal obesity, waist-height ratio, impaired fasting glucose (IFG), HOMA2-IR and metabolic syndrome. Early-onset ID was also high (IR 14.77 per 1000 person-years, 95%CI 14.21–15.35), and risk factors included HOMA-IR and IFG. Our ID predictive model included age, hypertriglyceridemia, IFG, hypertension and abdominal obesity as predictors (Dxy = 0.487, c-statistic = 0.741) and had higher predictive accuracy compared to FINDRISC and Cambridge risk scores. ID in apparently healthy middle-aged Mexican adults is currently at an alarming rate. The constructed models can be implemented to predict diabetes risk and represent the largest prospective effort for the study metabolic diseases in Latin-American population.

6 December 2012 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
BHBlake E Haas
Blake E Haas
SHSteve Horvath
Steve Horvath
KPKirsi Pietiläinen
Kirsi Pietiläinen
RCRita Cantor
Rita Cantor
ENElina Nikkola
Elina Nikkola
PPPäivi Pajukanta
Päivi Pajukanta
High serum triglyceride (TG) levels is an established risk factor for coronary heart disease (CHD). Fat is stored in the form of TGs in human adipose tissue. We hypothesized that gene co-expression networks in human adipose tissue may be correlated with serum TG levels and help reveal novel genes involved in TG regulation. Gene co-expression networks were constructed from two Finnish and one Mexican study sample using the blockwiseModules R function in Weighted Gene Co-expression Network Analysis (WGCNA). Overlap between TG-associated networks from each of the three study samples were calculated using a Fisher’s Exact test. Gene ontology was used to determine known pathways enriched in each TG-associated network. We measured gene expression in adipose samples from two Finnish and one Mexican study sample. In each study sample, we observed a gene co-expression network that was significantly associated with serum TG levels. The TG modules observed in Finns and Mexicans significantly overlapped and shared 34 genes. Seven of the 34 genes (ARHGAP30, CCR1, CXCL16, FERMT3, HCST, RNASET2, SELPG) were identified as the key hub genes of all three TG modules. Furthermore, two of the 34 genes (ARHGAP9, LST1) reside in previous TG GWAS regions, suggesting them as the regional candidates underlying the GWAS signals. This study presents a novel adipose gene co-expression network with 34 genes significantly correlated with serum TG across populations.

21 May 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
FRFabiola Mabel Del Razo-Olvera
Fabiola Mabel Del Razo-Olvera
AMAngélica J. Martin-Vences
Angélica J. Martin-Vences
GBGriselda X. Brito-Córdova
Griselda X. Brito-Córdova
DEDaniel Elías-López
Daniel Elías-López
MLMaría Victoria Landa-Anell
María Victoria Landa-Anell
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
Purpose: To describe the primary barriers to adequately adhering to a structured nutritional intervention. Patients and methods: A total of 106 participants diagnosed with dyslipidemia and without a medical nutrition therapeutic plan were included in this two-year study conducted at the INCMNSZ dyslipidemia clinic in Mexico City. All patients were treated with the same structured strategies, including three face-to-face visits and two telephone follow-up visits. Diet plan adherence was evaluated at each site visit through a 3-day or 24-h food recall. Results: Barriers to adhere to the nutritional intervention were: lack of time to prepare their meals (23%), eating outside the home (19%), unwillingness to change dietary patterns (14%), and lack of information about a correct diet for dyslipidemias (14%). All barriers decreased significantly at the end of the intervention. Female gender, current smoking, and following a plan of more than 1500 kcal (R2 = 0.18 and p-value = 0.004) were associated with good diet adherence. Participants showed good levels of adherence to total caloric intake at visit 2 and 3, reporting 104.7% and 95.4%, respectively. Adherence to macronutrient intake varied from 65.1% to 126%, with difficulties in adhering to recommended carbohydrate and fat consumption being more notable. Conclusion: The study findings confirm that a structured nutritional intervention is effective in reducing barriers and improving dietary adherence and metabolic control in patients with dyslipidemias. Health providers must identify barriers to adherence early on to design interventions that reduce these barriers and improve adherence.

AMAlexandro Martagón
Alexandro Martagón
CFCarlos A. Fermín-Martínez
Carlos A. Fermín-Martínez
NANeftali Eduardo Antonio-Villa
Neftali Eduardo Antonio-Villa
RMRoopa Mehta
Roopa Mehta
PAPaloma Almeda-Valdés
Paloma Almeda-Valdés
CACarlos A. Aguilar-Salinas
Carlos A. Aguilar-Salinas
Arterial stiffness may be associated with glucose metabolism parameters, such as HbA1c, mainly via insulin resistance. We aimed to investigate the association between arterial stiffness and HbA1c and explore the mediator effect of insulin resistance. In this cross-sectional study, arterial stiffness (pulse-wave velocity; PWV), HbA1c, and insulin resistance (METS-IR) were determined in Hispanic adults. In addition to sex and age, various biochemical measurements (glucose, lipid profile, etc.) and adipose tissue (fat mass and visceral fat mass) were considered as potential confounding variables. A multivariate regression analysis shows that HbA1c is associated with PWV, even after adjusting for several confounding variables. Importantly, the results show that insulin resistance mediated 17.9% of the effect of HbA1c over PWV. In conclusion, HbA1c may be a potential resource for predicting arterial stiffness due to the influence of insulin resistance in Hispanic subjects.